查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545580

大肠桿菌检测的全球市场

E. Coli Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球大肠桿菌检测市场将达到 32 亿美元

全球大肠桿菌检测市场预计 2023 年为 23 亿美元，预计到 2030 年将达到 32 亿美元，2023 年至 2030 年复合年增长率为 5.1%。环境测试最终用途是本报告分析的细分市场之一，预计复合年增长率为 5.7%，到分析期结束时将达到 20 亿美元。在分析期间，临床测试最终用途细分市场的复合年增长率预计为 4.2%。

美国市场预估为6.114亿美元，中国预期复合年增长率为8.6%

预计 2023 年美国大肠桿菌检测市场规模将达 6.114 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到7.037亿美元，2023-2030年分析期间复合年增长率为8.6%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.6% 和 5.6%。在欧洲，德国的复合年增长率预计为 2.7%。

全球大肠桿菌检测市场 - 主要趋势和驱动因素总结

什么是大肠桿菌测试？

大肠桿菌检测是临床和环境环境中用于检测大肠桿菌是否存在的重要程序，可显示粪便污染和有害病原体的潜在存在。此测试对于预防食物中毒爆发和确保水质至关重要。虽然大肠桿菌通常是无害的，但也有一些致病类型，例如大肠桿菌 O157，它会导致严重腹痛、腹泻和呕吐。快速且准确地检测这些细菌对于有效控制和治疗感染疾病的医疗保健以及预防受污染的食品和水供应引起的广泛爆发至关重要。

大肠桿菌测试是如何演变的？

支持大肠桿菌测试的调查方法已经从传统的基于培养的测试显着进步到更快速的分子技术。传统方法虽然高度可靠，但需要几天时间才能得出结果，而聚合酵素链锁反应(PCR) 和酵素结合免疫吸附检测法(ELISA) 等现代分子技术可以在数小时内获得结果。这些治疗方法进展大大减少了医疗和食品安全专业人员识别潜在疫情和实施必要控制所需的时间，从而降低了公共卫生风险并改善了食品生产和水处理设施的安全通讯协定。

哪些技术将塑造大肠桿菌测试的未来？

生物技术和微生物学的新技术正在进一步提高大肠桿菌检测的效率和准确性。基于 CRISPR 的生物感测器和次世代定序(NGS) 等创新正在为快速鑑定细菌菌株设定新标准。这些技术不仅减少了检测时间，还提供了识别抗生素抗药性的能力，从而增强了治疗和介入的策略应用。此外，人工智慧 (AI) 在诊断过程中的整合开始发挥关键作用，演算法可预测疫情爆发并自动监测各种环境中的大肠桿菌水平，支持积极的公共卫生措施。

大肠桿菌检测市场扩大的驱动力是什么？

大肠桿菌检测市场的成长是由多种因素推动的，这些因素反映了多个行业对快速、可靠的检测解决方案不断增长的需求。公众健康意识以及有关食品安全和水质的严格监管标准是主要的成长动力。随着全球食品供应链变得更加复杂，有效微生物监测的需求不断增加，因此需要强有力的测试通讯协定来确保消费者安全。提供更快、更准确测试选项的技术进步也为市场扩张做出了重大贡献。此外，健康意识的增强和大肠桿菌相关疾病发生率的增加正迫使食品和饮料行业和水资源管理务部门投资于更好的测试和检测系统。这些动态证实，技术创新、监管要求以及公共安全和健康的迫切需求正在推动市场发展。

受访企业范例（共14家）

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP11661

Global E. Coli Testing Market to Reach US$3.2 Billion by 2030

The global market for E. Coli Testing estimated at US$2.3 Billion in the year 2023, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Environmental Testing End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Clinical Testing End-Use segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$611.4 Million While China is Forecast to Grow at 8.6% CAGR

The E. Coli Testing market in the U.S. is estimated at US$611.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$703.7 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global E. Coli Testing Market - Key Trends and Drivers Summarized

What Is E. Coli Testing and Why Is It Crucial?

E.coli testing is a critical procedure used in both clinical and environmental settings to detect the presence of Escherichia coli bacteria, which can indicate fecal contamination and the potential presence of harmful pathogens. This testing is essential in preventing outbreaks of foodborne illnesses and ensuring water quality. E. coli strains, while often harmless, can include virulent types such as E. coli O157, which cause severe abdominal cramps, diarrhea, and vomiting. Rapid and accurate detection of these bacteria is crucial in healthcare to manage and treat infections effectively and in public health to prevent widespread outbreaks from contaminated food or water supplies.

How Has E. Coli Testing Evolved Over the Years?

The methodology behind E. coli testing has seen substantial advancements, moving from traditional culture-based tests to more rapid molecular techniques. Traditional methods, while reliable, require several days to yield results, whereas modern molecular techniques, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA), can provide results within hours. These advancements significantly reduce the time health professionals and food safety experts need to identify potential outbreaks and implement necessary controls, thereby minimizing public health risks and improving safety protocols in food production and water treatment facilities.

What Technologies Are Shaping the Future of E. Coli Testing?

Emerging technologies in biotechnology and microbiology are further refining the efficiency and accuracy of E. coli testing. Innovations such as CRISPR-based biosensors and next-generation sequencing (NGS) are setting new standards in the rapid identification of bacterial strains. These technologies offer not only faster detection times but also the ability to identify antibiotic resistance profiles, enhancing the strategic application of treatments and interventions. Additionally, the integration of artificial intelligence (AI) in diagnostic processes is beginning to play a pivotal role, with algorithms that can predict outbreaks and automate the monitoring of E. coli levels in various environments, thus supporting proactive public health measures.

What Drives the Expansion of the E. Coli Testing Market?

The growth in the E. coli testing market is driven by several factors, reflecting an increased demand for fast, reliable testing solutions across multiple sectors. Public health awareness and stringent regulatory standards concerning food safety and water quality are primary growth drivers. As global food supply chains become more complex, the need for effective microbial monitoring escalates, necessitating robust testing protocols to ensure consumer safety. Technological advancements that offer quicker, more accurate testing options are also major contributors to market expansion. Furthermore, the rise in health-conscious consumer behavior, coupled with an increase in outbreaks of E. coli-related illnesses, compels food and beverage industries and water management authorities to invest in better testing and detection systems. These dynamics underscore a market driven by innovation, regulatory demands, and the essential need for public safety and health.

Select Competitors (Total 14 Featured) -

  • Accugen Laboratories, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin SpA
  • Eiken Chemical Co., Ltd.
  • Enzo Life Sciences, Inc.
  • InstantLabs
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Mobidiag
  • Pro-Lab Diagnostics, Inc.
  • QIAGEN GmbH
  • Romer Labs, Inc.
  • Vivione Biosciences, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • E. Coli Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Foodborne Illnesses Drives Demand for E. Coli Testing Solutions
    • Advances in Molecular Diagnostic Technologies Propel Growth in E. Coli Testing Market
    • Increasing Focus on Food Safety and Regulatory Compliance Strengthens Business Case for E. Coli Testing
    • Expansion of E. Coli Testing in Water and Environmental Monitoring Spurs Demand for Rapid Detection Solutions
    • Growing Applications of E. Coli Testing in Agriculture and Animal Husbandry Drive Market Expansion
    • Rising Demand for E. Coli Testing in Water Treatment and Quality Control Expands Addressable Market
    • Growing Emphasis on Consumer Awareness and Education Drives Adoption of E. Coli Testing in Retail and Food Service
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for E. Coli Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Environmental Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Environmental Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Clinical Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World E. Coli Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • JAPAN
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • CHINA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • EUROPE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for E. Coli Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • FRANCE
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • GERMANY
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for E. Coli Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • INDIA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for E. Coli Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for E. Coli Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for E. Coli Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030
  • AFRICA
    • E. Coli Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for E. Coli Testing by End-Use - Environmental Testing and Clinical Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for E. Coli Testing by End-Use - Percentage Breakdown of Value Sales for Environmental Testing and Clinical Testing for the Years 2014, 2024 & 2030

IV. COMPETITION